PQ 799
799. Deputy Aodhán Ó Ríordáin asked the Minister for Health if his attention has been drawn to the drug dupilumab; if Ireland is one of only two countries in the EU in which the drug is not available as part of the health services drugs list; if his further attention has been drawn to a submission by a foundation (details supplied) regarding the efficacy of the drug and the potential impact on suitable patients; and if any progress has been made in making the drug more widely available to patients here under the community drugs schemes [25326/20]
Introduced
22 September 2020
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
22 September 2020
Summary
799. Deputy Aodhán Ó Ríordáin asked the Minister for Health if his attention has been drawn to the drug dupilumab; if Ireland is one of only two countries in the EU in which the drug is not available as part of the health services drugs list; if his further attention has been drawn to a submission by a foundation (details supplied) regarding the efficacy of the drug and the potential impact on suitable patients; and if any progress has been made in making the drug more widely available to patients here under the community drugs schemes [25326/20]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products
Medicinal Products
xml · EN · 22 September 2020
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2020-09-22/799/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2020-09-22/pq_799